Anvisa board appointment highlights Brazilian hot topics
This article was originally published in Clinica
Executive Summary
Jaime César de Moura Oliveira has joined the four-member directorship of Brazil’s healthcare regulatory agency, Anvisa. Mr Oliveira enters the agency with a background that includes ministerial legal support roles and his areas of expertise are bioethics, biosecurity and environmental law. His appointment was approved by the Senate’s social affairs committee during a meeting to discuss the regulatory themes he was most interested in. The themes included: the importance of cultivating the agency’s public consultations process as the means of ensuring the best adoption of Anvisa’s policies and guidance; and the war on clandestine and counterfeit healthcare products.